Consistent with TCGA pan‐cancer data (Figure S6A, Supporting Information), our proteomics data indicated that the abundance of CBX3 was globally elevated in GI cancers (Figure S9A, Supporting Information). The gene discussed is CBX3; the disease is cancer.